製品の概要

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab23357 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA 1/1000.

ターゲット情報

  • 関連性Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.
  • 別名
    • Morphine 6 antibody

Anti-Morphine antibody [3A6] 画像

  • A competitive ELISA was performed using various drugs at a concentration of 10 ng/ml. Only morphine was able to block the binding of ab23357 to the antigen. 1. Positive control. 2. Methamphetamine 3. Morphine 4. Amphetamine 5. Benzoylecgonine 6. MDMA

Anti-Morphine antibody [3A6] (ab23357) 使用論文

ab23357 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab23357.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"